Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa – a systematic review

BMC Public Health

Till Bärnighausen²  Megan B Murray¹  Stephen O Agboola³  Devra M Barter³ 

[1] Department of Epidemiology, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA;Africa Centre for Health and Population Studies, University of KwaZulu-Natal, KwaZulu-Natal, Mtubatuba, South Africa;Department of Global Health and Population, Harvard School of Public Health, 677 Huntington Avenue, Boston, MA 02115, USA

关键词: Africa;    Out-of-pocket costs;    Economic impact;    Tuberculosis;   

Others  :  1162839
DOI  :  10.1186/1471-2458-12-980

 received in 2012-04-15, accepted in 2012-10-22,  发布年份 2012

【 摘 要 】

Background

Tuberculosis (TB) is known to disproportionately affect the most economically disadvantaged strata of society. Many studies have assessed the association between poverty and TB, but only a few have assessed the direct financial burden TB treatment and care can place on households. Patient costs can be particularly burdensome for TB-affected households in sub-Saharan Africa where poverty levels are high; these costs include the direct costs of medical and non-medical expenditures and the indirect costs of time utilizing healthcare or lost wages. In order to comprehensively assess the existing evidence on the costs that TB patients incur, we undertook a systematic review of the literature.

Methods

PubMed, EMBASE, Science Citation Index, Social Science Citation Index, EconLit, Dissertation Abstracts, CINAHL, and Sociological Abstracts databases were searched, and 5,114 articles were identified. Articles were included in the final review if they contained a quantitative measure of direct or indirect patient costs for treatment or care for pulmonary TB in sub-Saharan Africa and were published from January 1, 1994 to Dec 31, 2010. Cost data were extracted from each study and converted to 2010 international dollars (I$).

Results

Thirty articles met all of the inclusion criteria. Twenty-one studies reported both direct and indirect costs; eight studies reported only direct costs; and one study reported only indirect costs. Depending on type of costs, costs varied from less than I$1 to almost I$600 or from a small fraction of mean monthly income for average annual income earners to over 10 times average annual income for income earners in the income-poorest 20% of the population. Out of the eleven types of TB patient costs identified in this review, the costs for hospitalization, medication, transportation, and care in the private sector were largest.

Conclusion

TB patients and households in sub-Saharan Africa often incurred high costs when utilizing TB treatment and care, both within and outside of Directly Observed Therapy Short-course (DOTS) programs. For many households, TB treatment and care-related costs were considered to be catastrophic because the patient costs incurred commonly amounted to 10% or more of per capita incomes in the countries where the primary studies included in this review were conducted. Our results suggest that policies to decrease direct and indirect TB patient costs are urgently needed to prevent poverty due to TB treatment and care for those affected by the disease.

【 授权许可】

   
2012 Barter et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

【 参考文献 】

• [1]World Health Organization: Global Tuberculosis Control 2010. Geneva: World Health Organization; 2010.
• [2]Lonnroth K, Jaramillo E, Williams BG, Dye C, Raviglione M: Drivers of tuberculosis epidemics: The role of risk factors and social determinants. Soc Sci Med 2009, 68:2240-2246.
• [3]Hoa NB, Tiemersma EW, Sy DN, Nhung NV, Gebhard A, Borgdorff MW, Cobelens FG: Household expenditure and tuberculosis prevalence in VietNam: prediction by a set of household indicators. Int J Tuberc Lung Dis 2011, 15(1):32-37.
• [4]Muniyandi M, Ramachandran R: Socioeconomic inequalities of tuberculosis in India. Expert Opin Pharmacother 2008, 9(10):1623-1628.
• [5]Siddiqi K, Barnes H, Williams R: Tuberculosis and poverty in the ethnic minority population of West Yorkshire: an ecological study. Commun Dis Public Health 2001, 4(4):242-246.
• [6]Spence DP, Hotchkiss J, Williams CS, Davies PD: Tuberculosis and poverty. BMJ 1993, 307(6907):759-761.
• [7]Holtgrave DR, Crosby RA: Social determinants of tuberculosis case rates in the United States. Am J Prev Med 2004, 26(2):159-162.
• [8]World Health Organization: Addressing poverty in TB control: Options for national TB control programems. Geneva: World Health Organization; 2005.
• [9]Fabricant SJ, Kamara CW, Mills A: Why the poor pay more: Household curative expenditures in rural Sierra Leone. Int J Health Plann Manage 1999, 14:179-199.
• [10]Elender F, Bentham G, Langford I: Tuberculosis mortality in England and Wales during 1982–1992: its association with poverty, ethnicity and AIDS. Soc Sci Med 1998, 46(6):673-681.
• [11]Hansel NN, Wu AW, Chang B, Diette GB: Quality of life in tuberculosis: patient and provider perspectives. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation 2004, 13(3):639-652.
• [12]Paton NI, Ng YM: Body composition studies in patients with wasting associated with tuberculosis. Nutrition (Burbank, Los Angeles County, Calif) 2006, 22(3):245-251.
• [13]Sagbakken M, Frich JC, Bjune G: Barriers and enablers in the management of tuberculosis treatment in Addis Ababa, Ethiopia: a qualitative study. BMC Public Health 2008, 8:11. BioMed Central Full Text
• [14]Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P, Raviglione MC: Tuberculosis control and elimination 2010–50: cure, care, and social development. Lancet 2010, 375(9728):1814-1829.
• [15]Organization WH: Involving Private Practitioners in Tuberculosis Control: Issues, Interventions, and Emerging Policy Framework. Geneva: World Health Organization; 2001.
• [16]Chang B, Wu AW, Hansel NN, Diette GB: Quality of life in tuberculosis: A review of English language literature. Qual Life Res 2004, 13:1633-1642.
• [17]Ahlburg DA: The economic impacts of tuberculosis. In Ministerial Conference. Amsterdam: The Stop TB Initative of the World Health Organization; 2000.
• [18]Russell S: The economic burden of illness for households in developing countries: A review of studies focusing on malaria, tuberculosis, and human immunodeficiency virus/acqiured immunodeficiency syndrome. American Journal of Tropical Medicine and Hygeine 2004, 71(Suppl 2):147-155.
• [19]McIntyre D, Thiede M, Dahlgren G, Whitehead M: What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts? Soc Sci Med 2006, 62(4):858-865.
• [20]Leive A, Xu K: Coping with out-of-pocket health payments: empirical evidence from 15 African countries. Bull World Health Organ 2008, 86(11):849-856.
• [21]Chimbindi N, Bärnighausen T, Newell M: Time and money: the costs of utilizing HIV and TB treatment in rural KwaZulu-Natal. Washington, D.C: AIDS 2012; 2012.
• [22]World Health Organization: 10 Facts on health financing. Geneva: World Health Organization; 2010.
• [23]Ukwaja KN, Modebe O, Igwenyi C, Alobu I: The economic burden of tuberculosis care for patients and households in Africa: a systematic review. Int J Tuberc Lung Dis 2012, 16(6):733-739.
• [24]Rajeswari R, Balasubramanian R, Muniyandi M, Geetharamani S, Thresa X, Venkatesan P: Socio-economic impact of tuberculosis on patients and family in India. Int J Tuberc Lung Dis 1999, 3(10):869-877.
• [25]Jackson S, Sleigh AC, Wang GJ, Liu XL: Poverty and the economic effects of TB in rural China. Int J Tuberc Lung Dis 2006, 10(10):1104-1110.
• [26]Pizzi LT, Lofland JH: Economic Evaluation in U.S. Health Care: Principles and Applications. Sudbury: Jones and Bartlett Publishers; 2006.
• [27]Raviglione M: The TB epidemic from 1992 to 2002. Tuberculosis 2003, 83:4-14.
• [28]Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D: The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. PLoS Med 2009, 6(7):e1000100.
• [29]OANDS currency converterAccessed April 3, 2011. Available at: http://www.oanda.com/ webcite
• [30]Steen TW, Masonde GN: Ngaka ya setswana, ngaka ya sekgoa or both? Health seeking behaviour in Batswana with pulmonary tuberculosis. Soc Sci Med 1999, 48(2):163-172.
• [31]Saunderson PR: An economic evaluation of alternative programme designs for tuberculosis control in rural Uganda. Soc Sci Med 1995, 40(9):1203-1212.
• [32]Inflation, average consumer prices. http://www.imf.org/external/pubs/ft/weo/2009/02/weodata/weoselgr.aspx webcite
• [33]World Development Indicators: World Development Indicators. http://data.worldbank.org/data-catalog/world-development-indicators webcite
• [34]Castillo-Riquelme M, McIntyre D, Barnes K: Household burden of malaria in South Africa and Mozambique: is there a catastrophic impact? Trop Med Int Health 2008, 13(1):108-122.
• [35]Limwattananon S, Tangcharoensathien V, Prakongsai P: Catastrophic and poverty impacts of health payments: results from national household surveys in Thailand. Bull World Health Organ 2007, 85(8):600-606.
• [36]Pradhan M, Prescott N: Social risk management options for medical care in Indonesia. Health Econ 2002, 11(5):431-446.
• [37]Ranson MK: Reduction of catastrophic health care expenditures by a community-based health insurance scheme in Gujarat, India: current experiences and challenges. Bull World Health Organ 2002, 80(8):613-621.
• [38]Claessens NJ, Gausi FF, Meijnen S, Weismuller MM, Salaniponi FM, Harries AD: High frequency of tuberculosis in households of index TB patients. Int J Tuberc Lung Dis 2002, 6(3):266-269.
• [39]Rathi SK, Akhtar S, Rahbar MH, Azam SI: Prevalence and risk factors associated with tuberculin skin test positivity among household contacts of smear-positive pulnionary tuberculosis cases in Umerkot, Pakistan. Int J Tuberc Lung Dis 2002, 6(10):851-857.
• [40]Wang PD, Lin RS: Tuberculosis transmission in the family. J Infect 2000, 41(3):249-251.
• [41]Aspler A, Menzies D, Oxlade O, Banda J, Mwenge L, Godfrey-Faussett P, Ayles H: Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, Zambia. Int J Tuberc Lung Dis 2008, 12(8):928-935.
• [42]Awofeso N: Implementing tuberculosis control programmes in Kaduna State, Nigeria. Int J Tuberc Lung Dis 1998, 2(4):336-337.
• [43]Bevan E: Tuberculosis treatment is expensive for patients in developing countries. BMJ 1997, 315(7101):187-188.
• [44]Brouwer JA, Boeree MJ, Kager P, Varkevisser CM, Harries AD: Traditional healers and pulmonary tuberculosis in Malawi. Int J Tuberc Lung Dis 1998, 2(3):231-234.
• [45]Cambanis A, Yassin MA, Ramsay A, Squire SB, Arbide I, Cuevas LE: Rural poverty and delayed presentation to tuberculosis services in Ethiopia. Trop Med Int Health 2005, 10(4):330-335.
• [46]Chard SE: Ugandan women's health beliefs, social networks and tuberculosis treatment-seeking. 3036337. United States -- Ohio: Case Western Reserve University; 2001.
• [47]Chard SE: Routes to Government TB Treatment: Private Providers, Family Support, and the Process of TB Treatment Seeking among Ugandan Women. Medical Anthropology Quarterly (New Series) 2009, 23(3):257-276.
• [48]Datiko DG, Lindtjorn B: Cost and cost-effectiveness of treating smear-positive tuberculosis by health extension workers in Ethiopia: An ancillary cost-effectiveness analysis of community randomized trial. PLoS One 2010, 5:2.
• [49]Edginton ME, Sekatane CS, Goldstein SJ: Patients' beliefs: do they affect tuberculosis control? A study in a rural district of South Africa. Int J Tuberc Lung Dis 2002, 6(12):1075-1082.
• [50]Floyd K, Skeva J, Nyirenda T, Gausi F, Salaniponi F: Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi. Int J Tuberc Lung Dis 2003, 7(9 SUPPL. 1):S29-S37.
• [51]Floyd K, Wilkinson D, Gilks C: Comparison of cost effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. BMJ 1997, 315(7120):1407-1411.
• [52]Gibson N, Boillot F, Jalloh H: The cost of tuberculosis to patients in Sierra Leone's war zone. Int J Tuberc Lung Dis 1998, 2(9):726-731.
• [53]Harper M, Ahmadu FA, Ogden JA, McAdam KP, Lienhardt C: Identifying the determinants of tuberculosis control in resource-poor countries: insights from a qualitative study in The Gambia. Trans R Soc Trop Med Hyg 2003, 97(5):506-510.
• [54]Kemp JR, Mann G, Simwaka BN, Salaniponi FM, Squire SB: Can Malawi's poor afford free tuberculosis services? Patient and household costs associated with a tuberculosis diagnosis in Lilongwe. Bull World Health Organ 2007, 85(8):580-585.
• [55]Mesfin MM, Newell JN, Madeley RJ, Mirzoev TN, Tareke IG, Kifle YT, Gessessew A, Walley JD: Cost implications of delays to tuberculosis diagnosis among pulmonary tuberculosis patients in Ethiopia. BMC Public Health 2010., 10
• [56]Moalosi G, Floyd K, Phatshwane J, Moeti T, Binkin N, Kenyon T: Cost-effectiveness of home-based care versus hospital care for chronically ill tuberculosis patients, Francistown, Botswana. Int J Tuberc Lung Dis 2003, 7(9 SUPPL. 1):S80-S85.
• [57]Needham DM, Godfrey-Faussett P: Economic barriers for tuberculosis patients in Zambia. Lancet 1996, 348(9020):134-135.
• [58]Needham DM, Godfrey-Faussett P, Foster SD: Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. Int J Tuberc Lung Dis 1998, 2(10):811-817.
• [59]Needham DM, Bowman D, Foster SD, Godfrey-Faussett P: Patient care seeking barriers and tuberculosis programme reform: a qualitative study. Health Policy 2004, 67(1):93-106.
• [60]Nganda B, Wang'Ombe J, Floyd K, Kangangi J: Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Machakos District, Kenya. Int J Tuberc Lung Dis 2003, 7(9 SUPPL. 1):S14-S20.
• [61]Okello D, Floyd K, Adatu F, Odeke R, Gargioni G: Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda. Int J Tuberc Lung Dis 2003, 7(9 Suppl 1):S72-S79.
• [62]Pocock D, Khare A, Harries AD: Case holding for tuberculosis in Africa: the patients’ perspective. Lancet 1996, 347:1258.
• [63]Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D: Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis 2003, 7(9 SUPPL. 1):S56-S62.
• [64]Sinanovic E, Kumaranayake L: Financing and cost-effectiveness analysis of public-private partnerships: Provision of tuberculosis treatment of South Africa. Cost Effectiveness and Resource Allocation 2006., 4
• [65]Vassall A, Seme A, Compernolle P, Meheus F: Patient costs of accessing collaborative tuberculosis and human immunodefi ciency virus interventions in Ethiopia. Int J Tuberc Lung Dis 2010, 14(5):604-610.
• [66]Wandwalo E, Robberstad B, Morkve O: Cost and cost-effectiveness of community based and health facility based directly observed treatment of tuberculosis in Dar es Salaam, Tanzania. Cost Effectiveness and Resource Allocation 2005., 3
• [67]Wilkinson D, Floyd K, Gilks CF: Costs and cost-effectiveness of alternative tuberculosis management strategies in South Africa - Implications for policy. South African Medical Journal 1997, 87(4):451-455.
• [68]Wyss K, Kilima P, Lorenz N: Costs of tuberculosis for households and health care providers in Dar es Salaam, Tanzania. Trop Med Int Health 2001, 6(1):60-68.
• [69]Floyd K: Costs and effectiveness–the impact of economic studies on TB control. Tuberculosis (Edinb) 2003, 83(1–3):187-200.
• [70]World Health Organization: Towards universal access: Scaling up priority HIV/AIDS interventions in the health sector. Geneva: World Health Organization; 2010.
• [71]Vassall A, Compernolle P: Estimating the resource needs of scaling-up HIV/AIDS and tuberculosis interventions in sub-Saharan Africa: a systematic review for national policy makers and planners. Health policy (Amsterdam, Netherlands) 2006, 79(1):1-15.
• [72]Beauliere A, Toure S, Alexandre PK, Kone K, Pouhe A, Kouadio B, Journy N, Son J, Ettiegne-Traore V, Dabis F, et al.: The financial burden of morbidity in HIV-infected adults on antiretroviral therapy in Cote d'Ivoire. PLoS One 2010, 5(6):e11213.
• [73]Boyer S, Marcellin F, Ongolo-Zogo P, Abega SC, Nantchouang R, Spire B, Moatti JP: Financial barriers to HIV treatment in Yaounde, Cameroon: first results of a national cross-sectional survey. Bull World Health Organ 2009, 87(4):279-287.
• [74]Mugisha F, Kouyate B, Gbangou A, Sauerborn R: Examining out-of-pocket expenditure on health care in Nouna, Burkina Faso: implications for health policy. Trop Med Int Health 2002, 7(2):187-196.
• [75]Ettling M, McFarland DA, Schultz LJ, Chitsulo L: Economic impact of malaria in Malawian households. Trop Med Parasitol 1994, 45(1):74-79.
• [76]Deressa W, Hailemariam D, Ali A: Economic costs of epidemic malaria to households in rural Ethiopia. Trop Med Int Health 2007, 12(10):1148-1156.
• [77]Zhu TY, Tam LS, Li EK: Cost-of-illness studies in systemic lupus erythematosus: A systematic review. Arthritis Care Res 2011, 63(5):751-760.
• [78]Bahadori K, Doyle-Waters MM, Marra C, Lynd L, Alasaly K, Swiston J, FitzGerald JM: Economic burden of asthma: a systematic review. BMC Pulm Med 2009, 9:24. BioMed Central Full Text
• [79]Cooper NJ: Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford) 2000, 39(1):28-33.